Pesquisa

Edição
Título
Autores
Obesity and associated diseases. Modern possibilities of prevention and treatment in real clinical practice
Markova T.
The first results of an observational retrospective study assessing the effectiveness of the use dapagliflozin in patients with type 2 diabetes mellitus in real clinical practice in the Russian Federation (GLORIA study)
Antsiferov M., Kvasnikov B.
Initiation of insulin therapy in patients with type 2 diabetes mellitus according to the Federal Diabetes Register in Moscow
Demidov N., Mishra O., Safronov T., Antsiferov M.
NEW POSSIBILITIES OF CARDIOVASCULAR RISK MANAGEMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Verbovoy A., Pashentseva A., Verbovaya N., Kosareva O.
The use of insulin glargine 300 lU/ml (Toujeo SoloStar®) in real clinical practice
Antsiferov M.
CURRENT POSSIBILITIES OF COMBINED THERAPY IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Chemikova N.
Advantages of the use of insulin aspart in insulin pump therapy in type 1 diabetic patients
Kovrigina E., Tyulganova V.
POTENTIALS FOR THE IMPROVEMENT OF TREATMENT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS USING HUMAN ULTRA-LONG INSULIN ANALOGUE DEGLUDEC IN OUTPATIENT SETTINGS
Kalashnikova M., Zilov A., Yazykova D., Likhodey N., Fadeev V.
ASSESSMENT OF LIVER FIBROSIS IN PATIENTS WITH DIABETES MELLITUS
Bakulin I., Vinnytskaya E., Sandler Y., Keiyan V., Rodionova S.
SVYaZ' MIKROBNOGO PEYZAZhA KIShEChNIKA S METABOLIChESKIM SINDROMOM
Plotnikova E., Krasnov O.
Preimushchestva svoevremennoy initsiatsii insulinoterapii. Rezul'taty rossiyskoy observatsionnoy programmy HUBIN
Chernikova N., Ivanova L., Abaeva F.
Effektivnost' i bezopasnost' primeneniya dvukhfaznogo analoga insulina NovoMiks 30 pri sakharnom diabete 2 tipa: ot klinicheskikh issledovaniy do real'noy praktiki
Surkova E.
Sakharnyy diabet i osteoporoz. Analiz kombinirovannogo podkhoda k lecheniyu
Doskina E.
METFORMIN - NADEZhNYY PARTNER V LEChENII PATsIENTOV S SAKhARNYM DIABETOM 2 TIPA
Petunina N., Kuzina I.
Osobennosti vedeniya patsientov s arterial'noy gipertenziey i sakharnym diabetom 2 tipa: vzglyad kardiologa
Statsenko M., Derevyanchenko M.
Rannyaya diagnostika i lechenie narushennoy glikemii natoshchak zamedlyaet tempy ee konversii v narushennuyu tolerantnost' k glyukoze i sakharnyy diabet 2 tipa
Demidova I., Boeva V.
INNOVATsIONNAYa SAKhAROSNIZhAYuShchAYa TERAPIYa: NOVAYa STRATEGIYa DLYa STAROY PROBLEMY
Antsiferov M., Schemthaner G., Ametov A.
Opyt ispol'zovaniya novoy formy gliklazida MV 60 mg (Diabeton MV 60 mg) v terapii bol'nykh sakharnym diabetom 2 tipa
Antsiferov M., Dorofeeva L.
Ratsional'naya farmakoterapiya SD 2 tipa: primenenie ingibitora DPP-4 saksagliptina i metformina v klinicheskoy praktike
Ametov A., Brashchenkova A.
METABOLIChESKIE POKAZATELI U MUZhChIN S SAKhARNYM DIABETOM 2 TIPA I IShEMIChESKOY BOLEZN'Yu SERDTsA
Verbovoy A., Vorozhtsova E., Orlova T.
HOW TO EFFECTIVELY MANAGE TWO MAJOR DEFECTS IN TYPE 2 DIABETES MELLITUS?
Biryukova E., Antsiferov M., Biryukova Y., Antsiferov M.
Hypoglycaemia in pregnant women with type 1 diabetes mellitus
Arbatskaya N., Tisel'ko A., Ignatova N., Arbatskaya N., Tiselko A., Ignatova N.
SAXAGLIPTIN (ONGLYZA ®) IN CONCEPTION OF EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Petunina N., Brashchenkova A., Petunina N., Brashcenkova A.
CURRENT APPROACHES TO THERAPY TYPE 2 DIABETES - EFFECT ON INSULIN RESISTANCE
Shishkova V., Shishkova V.
PHARMACOECONOMIC ASPECTS OF USE OF SULFONYLUREA MEDICATIONS IN INSULIN-INDEPENDENT DIABETES
Rudakova A., Rudakova A.
AUTONOMIC NEUROPATHY IN DIABETES MELLITUS: CLINICAL MANIFESTATIONS, DIAGNOSIS AND TREATMENT
Barinov A., Novosadova M., Barinov A., Novosadova M.
Comparison of treatment with insulin glargine and insulin Humulin NPH
Dvoryashina I., Dvoryashina I.
KORREKTOR TKANEVOGO METABOLIZMA SOLKOSERIL V LEChENII DIABETIChESKIKh OSLOZhNENIY
Grigoryan L.
ROSIGLITAZON: BEZOPASNOST', EFFEKTIVNOST' I VLIYaNIE NA KARDIOVASKULYaRNYE ISKhODY U PATsIENTOV S SAKhARNYM DIABETOM TIPA 2
Petunina N., Antsiferov M.
Effect of alpha-lipoic acid (Tiogamma) on the quality of life of patients with diabetic peripheral polyneuropathy
Kapustina L., Nesterova O., Boyko A., Stulin I., Antsiferov M., Kapustina L., Nesterova O., Boiko A., Stulin I., Anciferov M.
Vildagliptin - a new dipeptidylpeptidase-4 inhibitor for the treatment of type 2 diabetes mellitus
Antsiferov M., Dorofeeva L., Anciferov M., Dorofeeva L.
Efficacy of gosogliptin in the treatment of type 2 diabetes mellitus: a clinical case
Smirnova E.
Efficacy and safety of the Russian GLP-1 receptor agonist Quincenta (semaglutide) in patients with type 2 diabetes mellitus in real clinical practice (QUINPROMIS study. Interim data)
Antsiferov M., Koteshkova O., Antsiferova D., Romashkina L., Golubeva Y.
Intestinal microbiota status in patients with type 2 diabetes mellitus depending on the presence of chronic pyelonephritis at pre-dialysis stages of chronic kidney disease – an observational case-control study
Sturov N., Popov S., Kobalava Z., Belikov I., Zhukov V., Lyapunova T., Meleshkevich T.
Modern aspects of detection and monitoring of preclinical stages of type 1 diabetes mellitus in children
Varlamova T., Vezikova N.
Screening, diagnosis and treatment of early carbohydrate metabolism disorders
Demidova I., Boeva V.
Metabolic effects of metformin in patients with type 2 diabetes mellitus and new coronavirus infection
Zhurtova I., Gubachikova A., Aramisova L., Anaeva L., Abdul Moati H.
How to improve the quality of type 2 diabetes mellitus management in routine clinical practice. experience of using a glycemic variability diary
Astamirova K., Gatina A., Gorbunova Y., Demidov N., Ivanenko T., Kolesnikova M., Lapteva O., Morozova I., Parshina V., Presnyakova O., Smirnova E., Smirnova N., Startseva M., Khamrazhanov Z., Kholmskaya N.
Glycemic variability diary as a tool for assessing the effectiveness of diabetes therapy. Clear and accessible. Case series
Smirnova E.
Modern possibilities for correcting the uric acid level and eliminating skin manifestations of gout
Vereshchagin E., Svechnikova E., Artemyeva N.
Obesity as a factor in the development of gestational diabetes mellitus
Osmanova S., Tsakhilova S., Tsarkova M., Saschenko A.
Carbohydrate metabolism disorders and osteoporosis
Alekseeva N.
Analysis of anxiety-depressive states of patients with psoriasis and diabetes mellitus
Morzhanaeva M., Shchepkina E.
Optimization of the diabetes screening questionnaire for patients with psoriasis
Morzhanaeva M., Svechnikova E.
Vasodilating beta-adrenoceptor blockers in post-myocardial infarction patients with type 2 diabetes
Shchukina E., Gromenkov V., Suprun Y., Mykhailichenko E., Beryozova E., Bagriy V., Golodnikov I.
Clinical experience of long-term observation of the efficacy of a fixed combination of insulin glargine and GLP-1RA lixisenatide in patients with type 2 diabetes mellitus who did not reach the target glycemia values with the use of oral antidiabetic drugs
Mkrtumyan A., Markova T.
The many faces of vitamin D
Verbovoy A., Dolgikh Y., Verbovaya N.
Do we know everything about the possibilities of metformin in the treatment of type 2 diabetes mellitus? Which of its combinations is the most studied, effective and available for the patient in the real practice of the endocrinologist?
Biryukova E., Solovyova I.
Insulin detemir and its place in the diabetes treatment: results of 15-year use
Girsh Y.
Problem of detection and pharmacological correction of anxious and depressive disorders in patients with type 2 diabetes mellitus
Sorokina Y., Zanozin A., Zanozina O., Runov G.
NEW ONCE-WEEKLY GLP-1 RECEPTOR AGONIST - A QUALITATIVE LEAP IN MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Demidova T.
Diabetic distal polyneuropathy: the principles of diagnostics and therapy
Komelyagina E., Antsiferov M.
ELDERLY PATIENT WITH TYPE 2 DIABETES MELLITUS: FOCUS ON ALOGLIPTIN
Petunina N., Terekhova A.
Effect of glucagon-like peptide-1 receptor agonist on cardiovascular risk markers in patients with type 2 diabetes mellitus
Mkrtumyan A., Podachina S., Sviridova M.
EFFICIENCY OF MULTICOMPONENT THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (CLINICAL CASE)
Koteshkova O., Molina L.
Kombinirovannaya tsitostaticheskaya i angioprotektivnaya terapiya bol'nykh psoriazom
Bakulev A., Utts S., Shtoda Y.
Sakharosnizhayushchaya terapiya i serdechno- sosudistaya bezopasnost'
Pashentseva A., Verbovoy A.
Alogliptin - effektivnyy i bezopasnyy ingibitor dipeptidilpeptidazy-4 v terapii bol'nykh sakharnym diabetom 2 tipa
Mkrtumyan A.
Issledovanie ORIGIN (Outcome Reduction with Initial Glargine INtervention) 2 goda spustya: chto novogo?
Glinkina I.
FAKTORY RISKA RAZVITIYa OSTEOPOROZA
Akimova D.
ISSLEDOVANIE SAVOR: OTKRYTIE NOVOY EPOKhI BEZOPASNOY FARMAKOTERAPII SAKhARNOGO DIABETA 2 TIPA
Yuryatin A.
Dolgosrochnaya bezopasnost' i effektivnost' insulina aspart u patsientov s sakharnym diabetom 1 tipa
Antsiferov M.
GIPOGLIKEMII V PATOGENEZE SERDEChNO-SOSUDISTOGO RISKA
Ruyatkina L., Ruyatkin D., Berezovskaya G.
SOVETNIK BOLYuSA": EFFEKTIVNOE I BEZOPASNOE UPRAVLENIE POSTPRANDIAL'NOY GLIKEMIEY U PATsIENTOV NA POMPOVOY INSULINOTERAPII
Ametov A., Valitov B., Chernikova N., Antsiferov M.
Naznachenie sakharosnizhayushchego preparata patsientu - chto eshche neobkhodimo, krome retsepta?
Antsiferov M., Galstyan G.
Pompovaya insulinoterapiya: novye tekhnologii v sovremennoy klinicheskoy praktike
Ametov A., Valitov B., Chernikova N., Antsiferov M.
PAINFUL DIABETIC POLYNEUROPATHY
Strokov I., Strokov I.
SULFONYLUREAS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS TODAY. IS THERE A PROSPECT?
Kononenko I., Smirnova O., Smirnova O., Kononenko I.
Insulin pump - advanced menu of experienced user
Arbatskaya N., Arbatsraya N.
IRBESARTAN I NEFROPROTEKTsIYa: VLIYaNIE NA TUBULOINTERSTITsIAL'NUYu TKAN' I FUNKTsIYu POChKI V TsELOM
Arutyunov G., Oganezova L.
COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N., Trukhina L., Petunina N., Truhina L.
ROLE OF SPECIALIZED NUTRITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: CLINICAL EXPERIENCE OF USING OF GLUCERNA SR
Antsiferov M., Morgunov L., Antsiferov M., Morgunov L.
ADIPONECTIN AND C-REACTIVE PROTEIN AS FACTORS OF CARDIOVASCULAR RISK IN MEN WITH TYPE 2 DIABETES MELLITUS
Morkovskikh N., Morkovskikh N.
New possibilities for diabetic peripheral neuropathy treatment
Komelyagina E., Antsiferov M., Komelyagina E., Antsiferov M.
SOVREMENNYY VZGLYaD NA INSULINOTERAPIYu U BOL'NYKh SAKhARNYM DIABETOM
Ametov A., Karpova E.
MEKhANIZM DEYSTVIYa I KLINIChESKOE PRIMENENIE METFORMINA (SIOFOR®): OBZOR LITERATURY
Demidova I., Gorokhova T.
Insulin pump therapy - a way to achieve clinical and metabolic compensation of the disease in children and adolescents with type 1 diabetes mellitus
Petryaykina E., Dukhareva O., Rybkina I., Pronina E., Mikhaylova T., Garyaeva I., Mandzhieva E., Petryaikina E., Duchareva O., Ryibkina I., Pronina E., Michailova T., Garyaeva I., Mandjieva E.
Clinical cases of management of patients with type 2 diabetes mellitus using GLP-1 receptor agonists
Kanavets N., Rebrova D.
Current trends in self-monitoring of glycemic levels
Koteshkova O., Antsiferov M., Antsiferova D.
The impact of disease duration and glycemic control of type 1 diabetes mellitus on the lipid profile and intima-media thickness in children
Sadykova D., Shaydullina M., Aksenova A., Galimova L.
Features of macro- and microvascular complications in patients with type 2 diabetes mellitus (observational case-control study)
Bagriy A., Stefanenko A., Mikhailichenko E., Stefanenko E., Sabelnikova Y.
The use of dulaglutide in real clinical practice in patients with type 2 diabetes mellitus in Moscow
Antsiferov M., Antsiferova D., Koteshkova O., Demidov N.
Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes mellitus: how to choose the right solution
Antsiferov M., Koteshkova O., Antsiferova D., Demidov N.
Dipeptyl peptidase type 4 inhibitors for modern therapy of type 2 diabetes mellitus
Demidov N.
Microcirculation disorders in diabetic patients
Zelenina T., Zemlianoi A., Salukhov V., Ismailov D.
Place of GLP-1 receptor antagonists and SGLT-2 inhibitors in modern therapy of type 2 diabetes mellitus
Antsiferov M., Koteshkova O., Dukhareva O., Demidov N., Novikova M.
The use of the last generation insulin analogues for the control of diabetes mellitus in real clinical practice
Koteshkova O., Dukhareva O., Demidov N., Antsiferov M.
Obesity: an invisible disease
Verbovoy A., Dolgikh Y., Verbovaya N., Lomonova T.
Ipragliflozin in the treatment of comorbid patients with type 2 diabetes mellitus
Chernikova N., Knyshenko O., Ivanova L.
Gestational diabetes mellitus: prevention of reproductive loss
Glavnova O., Shelygin M., Salukhova A.
Possibilities of using taurine in the treatment of psychovegetative disorders in patients with type 2 diabetes mellitus
Demicheva T.
Modern topical treatment of psoriasis in diabetic patients
Lykova S., Nemchaninova O., Svechnikova E., Morzhanayeva M.
Early pathogenetic combined therapy of sugar diabetes type 2: focus on insulin resistance
Ametov A., Tertychnaya E.
The place of glyflozins in the management of type 2 diabetes mellitus
Sharonova L., Verbovoy A.
Diabetic autonomic neuropathy: problems of diagnosis and therapy
Kurnikova I., Yurovsky A.
Features of glycemic control in patients with type 2 diabetes mellitus and chronic heart failure
Demidova T., Titova V.
Efficiency of different schemes of antihelicbacter therapy in patients with chronic gastroduodenal diseases and type 2 diabetes mellitus
Fedorchenko Y., Martynyuk M.
Fixed-dose combinations in the therapy of type 2 diabetes mellitus: the way to achieving good glycemic control
Biryukova E.
ANGIOTENSIN II RECEPTOR BLOCKERS AND ENDOTHELIAL DYSFUNCTION: FOCUS ON NEPHROCEREBRAL INTERACTIONS
Murkamilov I., Aytbaev K., Yusupov F.
Modern approaches to the treatment of patients with type 2 diabetes mellitus
Antsiferov M., Fadeev V., Morgunova T.
201 - 300 de 369 resultados << < 1 2 3 4 > >> 
Dicas:
  • Palavras-chave são sensíveis a maiúsculas
  • Preposições e conjunções ingleses são ignoradas
  • Busca é feita por todos os palavras-chave (agente AND experimentador) por omissão
  • Use OR para pesquisar um termo exato, ex.: educação OR formação
  • Use parênteses para criar frases complexas, ex.: arquivo de ((revistas OR conferências) NOT teses)
  • Para pesquisar uma frase precisa use aspas duplas, ex.: "investigações científicas"
  • Exclua uma palavra utilizando o sinal - (hífen) ou operador NOT; ex.: concurso-de beleza ou concurso NOT de beleza
  • Use * como caractere-coringa, ex.: científic* recuperará as palavras "científico", "científicos", etc.